Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
104.50
Ask:
106.50
Spread: 2.00 (1.914%)
Market Cap: £305.38m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

CEO Suspension

18 Mar 2025 12:51

RNS Number : 1583B
Big Technologies PLC
18 March 2025
 

18 March 2025

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

CEO Suspension

Big Technologies plc, the UK-based remote people monitoring technology company, announces that owing to concerns in respect of Sara Murray's conduct which have recently become apparent in connection with the subject matter and conduct of the Litigation (defined below) following proactive steps taken, under the lead of Alexander Brennan, Interim Chairman of Big Technologies, the Company will undertake further investigations. Whilst those investigations are underway the Board has resolved to suspend Sara Murray from her role as Chief Executive Officer with immediate effect.

As previously announced, the Company continues to defend a claim filed with the High Court of Justice of England and Wales in 2023. The claim has been brought by a small number of former shareholders in Buddi Limited, a subsidiary of the Company, relating to the acquisition of Buddi Limited, dating back to 2018 (the "Litigation"). The Company continues to review its position and to take advice from its Legal Counsel in connection with all aspects of the Litigation and the Board will provide further updates in relation to the Litigation as necessary.

During the period of Sara Murray's suspension, Daren Morris, the current Chief Financial Officer of the Company will assume the role and responsibilities of interim Chief Executive Officer to provide leadership and ensure business continuity.

 

Charles Lewinton in his role as Chief Operating Officer will continue to work with Daren Morris to ensure operational continuity.

 

Current Trading and Outlook

The Group has had a positive start to the financial year and continues to perform in line with current market expectations*. The Group had cash balances in excess of £100 million as at the end of February 2025.

As stated in the Trading Update which the Company announced on 28 January 2025, visibility on the base-level of business for 2025 is very good and the Company expects to see growth in the Monthly Recurring Revenue throughout the year, assuming no adverse movements in foreign exchange. Group sales and profitability are still expected to remain in line with current market expectations*, and the start of the current financial year has been positive.

The Group is well-positioned, with the financial flexibility to invest in new technologies, and has a clear strategy for business development and investment in target markets, where it is currently under-represented. The electronic monitoring market remains supported by favourable tailwinds and with the Group's clear strategy and market-leading products, the Board remains confident that the Group will return to growth with 2025 Revenues exceeding those achieved in 2024.

* The Company has compiled forecasts from five analysts with current market forecasts for 2024 revenue to be in the range of £50.0 to £50.2m, with a consensus of £50.1m, and for adjusted EBITDA to be in the range of £26.0 to £27.1m, with a consensus of £26.7m.

 

 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Alexander Brennan (Interim Chairman)

Daren Morris (Interim Chief Executive Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSFVAITLIE
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.